Jarden Life Sciences today published a white paper discussing available strategies to help to reduce risk and variability in temperature-sensitive pharmaceutical sampling. The paper outlines the advantages of active systems for temperature assurance, which offer decreased risk, increased potential for return-on-investment, and improved efficiencies for temperature-sensitive pharmaceutical sampling when compared to passive systems.
Download a complimentary copy of the white paper, “Eliminating Variability: The Solution to Temperature-Sensitive Pharmaceutical Sampling.”
In the white paper, Jarden Life Sciences highlights the growing number of biologic pharmaceuticals as a contributing factor to the need for reliable methods of distributing temperature-sensitive products in the last mile of the supply chain.
“As the demand for and prevalence of biologic drugs increases, so does the need for effective, efficient and compliant solutions for distributing temperature-sensitive drug samples,” said Scott Dyvig, Program Manager, Packaging Engineering and Technical Services at Jarden Life Sciences. “Active temperature-control systems, like Jarden Life Sciences’ Envirocooler™ ActiVault™, offer a reliable and consistent temperature environment for the last mile of product distribution, increasing efficiencies and reducing costs over time.”
Dyvig will delve further into temperature-sensitive pharmaceutical sampling this week during the 13th Annual Cold Chain GDP & Temperature Management Logistics Global Forum, where he will host a workshop on “Best Practices in Sales Representative Sampling” to address the decision-making process relative to packaging and handling temperature-sensitive product samples. The Jarden Life Sciences white paper on temperature-sensitive pharmaceutical sampling provides insight into:
- The Impact of Biologic Drug Development on Product Sampling
- Active vs. Passive Temperature-Control Systems: Risks and Rewards
- Active Systems as a Business Solution
- Key Elements in the Last Mile of the Cold Chain Distribution Process
The alternative to active systems are passive cooling systems, which require additional steps to set up and maintain and are more vulnerable to human operator error when creating the cooling environment needed to sustain the temperature range for certain pharmaceuticals, such as biologics. They are also susceptible to external factors that may impact product efficacy. Active systems, in contrast, rely on a power source that can provide a more reliable and consistent temperature for the transport of biologic samples, substantially decreasing the number of steps taken by the user and reducing variability caused by external environmental changes.
Jarden Life Sciences’ Envirocooler ActiVault enables pharmaceutical companies to deliver temperature-sensitive products to healthcare providers efficiently.
The Envirocooler ActiVault helps sales representatives protect the safety, efficacy and integrity of samples. It can also lead to a potential of more than 38,000 minutes of sales time saved over a five-year span when compared with passive systems, ultimately strengthening relationships with healthcare providers and improving conversion success rates associated with product launches.
“Hand sampling is critical to business success for pharmaceutical companies and their temperature-sensitive products,” continued Dyvig. “Using an active system during hand sampling reduces variability and therefore helps ensure that sample product efficacy and potency are not compromised.”
About Jarden Life Sciences
Jarden Life Sciences is a leader in the design of thermal packaging solutions, with capabilities in developing customized primary and secondary packaging as well as off-the-shelf solutions. Jarden Life Sciences offers a rich pool of resources, including specialists in thermal science, logistics, applied materials, and engineering, as well as the global resources of Jarden Corporation to offer the industry’s smartest packaging solutions. Connect with Jarden Life Sciences on Twitter @JardenLS and on LinkedIn, at https://www.linkedin.com/company/10107041.
About Jarden Corporation
Jarden Corporation is a diversified, global consumer products company with a portfolio of over 120 trusted, authentic brands. Jarden’s record of strong financial performance and organic growth is supported by a focused operating culture coupled with value enhancing acquisitions and shareholder focused capital allocation. Jarden operates in three primary business segments through a number of well recognized brands, including: Branded Consumables: Ball®, Bee®, Bernardin®, Bicycle®, Billy Boy®, Crawford®, Diamond®, Envirocooler®, Fiona®, First Alert®, First Essentials®, Hoyle®, Kerr®, Lehigh®, Lifoam®, Lillo®, Loew-Cornell®, Mapa®, Millefiori®, NUK®, Pine Mountain®, Quickie®, Spontex®, Tigex®, Waddington®, Yankee Candle® and YOU®; Outdoor Solutions: Abu Garcia®, AeroBed®, Berkley®, Campingaz® and Coleman®, Dalbello®, ExOfficio®, Fenwick®, Greys®, Gulp!®, Hardy®, Invicta®, K2®, Marker®, Marmot®, Mitchell®, PENN®, Rawlings®, Shakespeare®, Squadra®, Stearns®, Stren®, Trilene®, Völkl® and Zoot®; and Consumer Solutions: Bionaire®, Breville®, Cadence®, Crock-Pot®, FoodSaver®, Health o meter®, Holmes®, Mr. Coffee®, Oster®, Patton®, Rainbow®, Rival®, Seal-a-Meal®, Sunbeam®, VillaWare® and White Mountain®. Headquartered in Florida, Jarden ranks #348 on the Fortune 500 and has over 35,000 employees worldwide. For further information about Jarden, please visit www.jarden.com.
For media inquiries:
Casey Myburgh
Casey.Myburgh@Ketchum.com
202-835-8876